These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11123013)

  • 21. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
    Shapiro LS; Prince RK; Buckingham RB; Rodnan GP
    J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of D-penicillamine on pulmonary findings in systemic sclerosis.
    Steen VD; Owens GR; Redmond C; Rodnan GP; Medsger TA
    Arthritis Rheum; 1985 Aug; 28(8):882-8. PubMed ID: 4026885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The toxicity of D-penicillamine in systemic sclerosis.
    Steen VD; Blair S; Medsger TA
    Ann Intern Med; 1986 May; 104(5):699-705. PubMed ID: 2938530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma).
    Medsger TA
    Arthritis Rheum; 1987 Jul; 30(7):832-4. PubMed ID: 3304300
    [No Abstract]   [Full Text] [Related]  

  • 25. (D)-penicillamine treatment in systemic sclerosis (scleroderma). Effect on nutritional capillary circulation.
    Mellstedt H; Fagrell B; Holm G; Björkholm M
    Scand J Rheumatol; 1977; 6(2):92-6. PubMed ID: 897590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of systemic sclerosis].
    van den Hoogen FH
    Z Rheumatol; 2006 Jul; 65(4):306, 308-10. PubMed ID: 16819640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective randomly selected cohort study of D-penicillamine treatment in rapidly progressive diffuse cutaneous systemic sclerosis of recent onset.
    Derk CT; Huaman G; Jimenez SA
    Br J Dermatol; 2008 May; 158(5):1063-8. PubMed ID: 18284395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosis.
    Calguneri M; Apras S; Ozbalkan Z; Ertenli I; Kiraz S; Ozturk MA; Celik I
    Clin Rheumatol; 2003 Oct; 22(4-5):289-94. PubMed ID: 14579158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term evaluation of penicillamine or cyclofenil in systemic sclerosis. Results from a two-year randomized study.
    Akesson A; Blom-Bülow B; Scheja A; Wollmer P; Valind S; Wollheim FA
    Scand J Rheumatol; 1992; 21(5):238-44. PubMed ID: 1439632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.
    Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin R; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold J
    Arthritis Rheum; 1999 Nov; 42(11):2372-80. PubMed ID: 10555033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial.
    Rook AH; Freundlich B; Jegasothy BV; Perez MI; Barr WG; Jimenez SA; Rietschel RL; Wintroub B; Kahaleh MB; Varga J
    Arch Dermatol; 1992 Mar; 128(3):337-46. PubMed ID: 1550365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of progressive systemic sclerosis (PSS) with penicillamine. Preliminary report of two cases.
    Tio H; van Wijk L; de Haan E
    Acta Med Scand; 1973 May; 193(5):477-80. PubMed ID: 4717327
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical and prognostic significance of antinuclear factors during D-penicillamine treatment (author's transl)].
    Helmke K; Velcovsky HG; Federlin K
    Dtsch Med Wochenschr; 1975 Oct; 100(43):2198-203. PubMed ID: 1080704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of systemic sclerosis.
    Medsger TA
    Rheum Dis Clin North Am; 1989 Aug; 15(3):513-31. PubMed ID: 2672135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.
    Steen VD; Medsger TA
    Arthritis Rheum; 1998 Sep; 41(9):1613-9. PubMed ID: 9751093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The current treatment of scleroderma.
    Oliver GF; Winkelmann RK
    Drugs; 1989 Jan; 37(1):87-96. PubMed ID: 2651089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [D-penicillamine: an outdated cure for systemic scleroderma?].
    Marie I; Lévesque H; Courtois H
    Rev Med Interne; 1999 Dec; 20(12):1077-81. PubMed ID: 10635068
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment.
    Bluestone R; Grahame R; Holloway V; Holt PJ
    Ann Rheum Dis; 1970 Mar; 29(2):153-8. PubMed ID: 5427411
    [No Abstract]   [Full Text] [Related]  

  • 39. Treating systemic sclerosis in 2001.
    Mouthon L; Agard C
    Joint Bone Spine; 2001 Oct; 68(5):393-402. PubMed ID: 11707005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D-penicillamine treatment in systemic sclerosis.
    Steen V
    J Rheumatol; 1991 Oct; 18(10):1435-7. PubMed ID: 1765965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.